Well Lead Medical Co., Ltd. (SHA:603309)
11.70
+0.18 (1.56%)
Apr 25, 2025, 9:45 AM CST
Well Lead Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
Net Income | 215.29 | 192.49 | 166.57 | 106.09 | 153.11 | 121.14 | Upgrade
|
Depreciation & Amortization | 63.26 | 63.26 | 65.52 | 57.74 | 48.55 | 42.58 | Upgrade
|
Other Amortization | 13.67 | 13.67 | 2.61 | 1.62 | 1.09 | 0.69 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.09 | -0.09 | -0.04 | -0 | -0.22 | 0.46 | Upgrade
|
Asset Writedown & Restructuring Costs | 0.46 | 0.46 | 7.57 | 0.56 | 12.58 | 9.9 | Upgrade
|
Loss (Gain) From Sale of Investments | -8.61 | -8.61 | -5.99 | 4.84 | 1.79 | -12.28 | Upgrade
|
Provision & Write-off of Bad Debts | 0.79 | 0.79 | -1.4 | 0.83 | 1.78 | -0.55 | Upgrade
|
Other Operating Activities | 17.32 | 30.5 | 27.78 | 21.9 | 22.57 | 21.71 | Upgrade
|
Change in Accounts Receivable | -74.04 | -74.04 | 59.98 | -20.32 | -3.74 | -9.17 | Upgrade
|
Change in Inventory | 8.28 | 8.28 | -5.21 | -36.94 | -31.14 | -5.82 | Upgrade
|
Change in Accounts Payable | -6.75 | -6.75 | 52.7 | 50.48 | 21.17 | 13.23 | Upgrade
|
Change in Other Net Operating Assets | 2.59 | 2.59 | 21 | 3.22 | - | - | Upgrade
|
Operating Cash Flow | 232.13 | 222.51 | 391.13 | 187.28 | 228.44 | 178.79 | Upgrade
|
Operating Cash Flow Growth | -3.01% | -43.11% | 108.84% | -18.02% | 27.77% | 98.91% | Upgrade
|
Capital Expenditures | -322.2 | -357.89 | -181.38 | -109.28 | -92.49 | -112.54 | Upgrade
|
Sale of Property, Plant & Equipment | -0.07 | 0.34 | 0.08 | 2.94 | 0.5 | 2.35 | Upgrade
|
Cash Acquisitions | - | - | - | -33.44 | -0.28 | -40 | Upgrade
|
Divestitures | - | - | - | - | -2.64 | 23.66 | Upgrade
|
Investment in Securities | -32.66 | 15.19 | -388.31 | -17.16 | -2 | 15 | Upgrade
|
Other Investing Activities | 15.32 | 17.91 | 9.67 | 0.6 | 1.15 | 19.51 | Upgrade
|
Investing Cash Flow | -339.61 | -324.45 | -559.93 | -156.34 | -95.75 | -92.02 | Upgrade
|
Long-Term Debt Issued | - | 338.44 | 177.1 | 134.9 | - | 40 | Upgrade
|
Total Debt Issued | 550.49 | 338.44 | 177.1 | 134.9 | - | 40 | Upgrade
|
Long-Term Debt Repaid | - | -215.93 | -169.55 | -75.27 | -91 | -72.5 | Upgrade
|
Total Debt Repaid | -320.23 | -215.93 | -169.55 | -75.27 | -91 | -72.5 | Upgrade
|
Net Debt Issued (Repaid) | 230.27 | 122.51 | 7.56 | 59.63 | -91 | -32.5 | Upgrade
|
Issuance of Common Stock | - | - | 0.69 | 417.66 | - | - | Upgrade
|
Repurchase of Common Stock | -1.06 | -1.06 | -1.36 | - | - | - | Upgrade
|
Common Dividends Paid | -161.36 | -106.84 | -45.49 | -58.56 | -50.6 | -33.68 | Upgrade
|
Other Financing Activities | 10.17 | -2.95 | -8.3 | -4.86 | 3.69 | 1.97 | Upgrade
|
Financing Cash Flow | 78.01 | 11.66 | -46.91 | 413.88 | -137.9 | -64.21 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.04 | 1.71 | 2.58 | -2.1 | -4.05 | -0.52 | Upgrade
|
Net Cash Flow | -29.51 | -88.57 | -213.14 | 442.72 | -9.26 | 22.04 | Upgrade
|
Free Cash Flow | -90.06 | -135.38 | 209.75 | 78 | 135.96 | 66.26 | Upgrade
|
Free Cash Flow Growth | - | - | 168.90% | -42.63% | 105.20% | 490.21% | Upgrade
|
Free Cash Flow Margin | -6.12% | -9.75% | 15.38% | 6.97% | 12.02% | 6.67% | Upgrade
|
Free Cash Flow Per Share | -0.31 | -0.46 | 0.72 | 0.30 | 0.52 | 0.26 | Upgrade
|
Cash Interest Paid | - | - | - | - | - | 0.55 | Upgrade
|
Cash Income Tax Paid | 34.7 | 43.92 | 51.41 | 45.9 | 65.82 | 51.06 | Upgrade
|
Levered Free Cash Flow | -218.06 | -234.44 | 151.53 | 58.19 | 79.36 | -21 | Upgrade
|
Unlevered Free Cash Flow | -210.95 | -228.74 | 156.45 | 63.5 | 85.88 | -12.52 | Upgrade
|
Change in Net Working Capital | 126.7 | 93.74 | -130.04 | -18.8 | 9.01 | 35.19 | Upgrade
|
Updated Oct 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.